Liu Y - Search Results

1

Mutations in exon 8 of TP53 are associated with shorter survival in patients with advanced lung cancer.

Liu Y, Xu F, Wang Y, Wu Q, Wang B, Yao Y, Zhang Y, Han-Zhang H, Ye J, Zhang L, Mao X, Zhang Z, Liu J, Zhu L, Guo R. Liu Y, et al. Among authors: liu j. Oncol Lett. 2019 Sep;18(3):3159-3169. doi: 10.3892/ol.2019.10625. Epub 2019 Jul 16. Oncol Lett. 2019. PMID: 31452792 Free PMC article.

2

Clinicopathologic characteristics and outcome of patients with different EGFR mutations.

Zhou S, Hu X, Wang Y, Li J, Zhou L, Hao X, Liu Y, Shi Y. Zhou S, et al. Among authors: liu y. Asia Pac J Clin Oncol. 2019 Jun;15(3):166-171. doi: 10.1111/ajco.13072. Epub 2018 Oct 11. Asia Pac J Clin Oncol. 2019. PMID: 30311393

3

Clinical Characteristics and Treatment Outcomes of 65 Patients With BRAF-Mutated Non-small Cell Lung Cancer.

Mu Y, Yang K, Hao X, Wang Y, Wang L, Liu Y, Lin L, Li J, Xing P. Mu Y, et al. Among authors: liu y. Front Oncol. 2020 Apr 28;10:603. doi: 10.3389/fonc.2020.00603. eCollection 2020. Front Oncol. 2020. PMID: 32411601 Free PMC article.

4

Investigation on the potential of circulating tumor DNA methylation patterns as prognostic biomarkers for lung squamous cell carcinoma.

Liu Y, Feng Y, Hou T, Lizaso A, Xu F, Xing P, Wang H, Kang Q, Zhang L, Shi Y, Hu X. Liu Y, et al. Transl Lung Cancer Res. 2020 Dec;9(6):2356-2366. doi: 10.21037/tlcr-20-1070. Transl Lung Cancer Res. 2020. PMID: 33489798 Free PMC article.

5

TGFBR2 mutation predicts resistance to immune checkpoint inhibitors in patients with non-small cell lung cancer.

Li T, Wang H, Xu J, Li C, Zhang Y, Wang G, Liu Y, Cai S, Fang W, Li J, Wang Z. Li T, et al. Among authors: liu y. Ther Adv Med Oncol. 2021 Aug 14;13:17588359211038477. doi: 10.1177/17588359211038477. eCollection 2021. Ther Adv Med Oncol. 2021. PMID: 34408796 Free PMC article.

6

Survival Outcomes of Patients With Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer With Leptomeningeal Metastasis.

Li N, Bian Z, Cong M, Liu Y. Li N, et al. Among authors: liu y. Front Oncol. 2022 Jan 20;11:723562. doi: 10.3389/fonc.2021.723562. eCollection 2021. Front Oncol. 2022. PMID: 35127465 Free PMC article.

7

[Classification and regression tree analysis of 154 patients with cancer of unknown primary].

Wang ZP, Liu YT, Yang J. Wang ZP, et al. Zhonghua Zhong Liu Za Zhi. 2010 Sep;32(9):690-3. Zhonghua Zhong Liu Za Zhi. 2010. PMID: 21122385 Chinese.

8

[Classification and regression tree analysis of clinical patterns that predict survival in 127 Chinese patients with advanced non-small cell lung cancer treated by gefitinib who failed to previous chemotherapy].

Wang Z, Guo J, Wang Y, Liu Y, Yang J. Wang Z, et al. Among authors: liu y. Zhongguo Fei Ai Za Zhi. 2011 Sep;14(9):699-703. doi: 10.3779/j.issn.1009-3419.2011.09.04. Zhongguo Fei Ai Za Zhi. 2011. PMID: 21924034 Free PMC article. Chinese.

9

[Classification and regression tree analysis of clinical patterns to predict the survival of patients with advanced non-small cell lung cancer treated with erlotinib].

Liu Y, Guo J, Wang Y, Yang J, Wang Z. Liu Y, et al. Zhongguo Fei Ai Za Zhi. 2011 Oct;14(10):785-9. doi: 10.3779/j.issn.1009-3419.2011.10.04. Zhongguo Fei Ai Za Zhi. 2011. PMID: 22008108 Free PMC article. Chinese.

10

[Association between different EGFR mutation status and survival in pemetrexed-based chemotherapy for advanced non-small cell lung cancer].

Jia B, He XH, Yang S, Wang ZP, Li JL, Wang Y, Wang HY, Xing PY, Liu YT, Shi YK. Jia B, et al. Among authors: liu yt. Zhonghua Yi Xue Za Zhi. 2013 Dec;93(46):3659-62. Zhonghua Yi Xue Za Zhi. 2013. PMID: 24534344 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

210,721 results

Search Page

Filters